🟢 Anixa Biosciences is trading 5.6% up today amid gains across major indexes

Anixa Biosciences is trading 5.6% higher at $2.92, with broader market strength potentially supporting shares.

• The S&P 500 is up 0.71%, the NASDAQ Composite is up 1.16%, and the Dow is up 0.52%.
• On October 1, the company announced that a second patient was treated in the highest-dose cohort of its ovarian cancer CAR-T trial. Available reporting does not directly connect this news to the October 2 move.